DUXAP9 and urinary bladder cancer: Chen et al. identified a lncRNA, LNMAT1 (Lymph Node Metastasis Associated Transcript 1), that epigenetically activates CCL2 expression, leading to TAM infiltration and promoting lymph node metastasis via VEGF-C excretion in bladder cancer [75].